Stock Research for BOLT

BOLT

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

BOLT Stock Chart & Research Data

The BOLT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BOLT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


BOLT Due diligence Resources & Stock Charts

The BOLT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BOLT Detailed Price Forecast - CNN Money CNN View BOLT Detailed Summary - Google Finance
Yahoo View BOLT Detailed Summary - Yahoo! Finance Zacks View BOLT Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View BOLT Trends & Analysis - Trade-Ideas Barrons View BOLT Major Holders - Barrons
NASDAQ View BOLT Call Transcripts - NASDAQ Seeking View BOLT Breaking News & Analysis - Seeking Alpha
Spotlight View BOLT Annual Report - CompanySpotlight.com OTC Report View BOLT OTC Short Report - OTCShortReport.com
TradeKing View BOLT Fundamentals - TradeKing Charts View BOLT SEC Filings - Bar Chart
WSJ View Historical Prices for BOLT - The WSJ Morningstar View Performance/Total Return for BOLT - Morningstar
MarketWatch View the Analyst Estimates for BOLT - MarketWatch CNBC View the Earnings History for BOLT - CNBC
StockMarketWatch View the BOLT Earnings - StockMarketWatch MacroAxis View BOLT Buy or Sell Recommendations - MacroAxis
Bullish View the BOLT Bullish Patterns - American Bulls Short Pains View BOLT Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View BOLT Stock Mentions - StockTwits PennyStocks View BOLT Stock Mentions - PennyStockTweets
Twitter View BOLT Stock Mentions - Twitter Invest Hub View BOLT Investment Forum News - Investor Hub
Yahoo View BOLT Stock Mentions - Yahoo! Message Board Seeking Alpha View BOLT Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for BOLT - SECform4.com Insider Cow View Insider Transactions for BOLT - Insider Cow
CNBC View BOLT Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BOLT - OTC Markets
Yahoo View Insider Transactions for BOLT - Yahoo! Finance NASDAQ View Institutional Holdings for BOLT - NASDAQ


Stock Charts

FinViz View BOLT Stock Insight & Charts - FinViz.com StockCharts View BOLT Investment Charts - StockCharts.com
BarChart View BOLT Stock Overview & Charts - BarChart Trading View View BOLT User Generated Charts - Trading View




Latest Financial News for BOLT


Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
Posted on Thursday March 21, 2024

– BDC-1001 (trastuzumab imbotolimod) Phase 2 studies in four HER2-positive tumor types advancing toward 2024 milestones– BDC-3042 Phase 1 study successfully cleared safety assessments in the first three dose level cohorts – Cash balance of $128.6 million as of December 31, 2023, anticipated to fund key milestones through late 2025 REDWOOD CITY, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapi


Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
Posted on Tuesday February 27, 2024

REDWOOD CITY, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will present a company overview at the TD Cowen 44th Annual Healthcare Conference on Tuesday, Mar. 5, at 2:50 p.m. EDT (11:50 a.m. PDT) in Boston, Massachusetts. A live webcast of the presentation will be available on the Events and Presentations page of Bolt’s website


Pacira Appoints Frank D. Lee as Chief Executive Officer
Posted on Thursday December 21, 2023

-- Transformational Leader Brings Three Decades of Global Experience in Pharmaceutical and Biotechnology Product Development and Commercialization -- -- Paul J. Hastings Named Chair of the Board -- -- Dave Stack to Remain in Advisory Role through August 2025 -- TAMPA, Fla., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced that its Board of Directors (th


Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®
Posted on Tuesday December 05, 2023

BDC-1001 is a Boltbody™ Immune-Stimulating Antibody Conjugate (ISAC) in Phase 2 development for HER2-positive breast, colorectal, endometrial, and gastroesophageal cancersPoster detailing trial design and rationale to be presented at the 2023 San Antonio Breast Cancer Symposium on Wednesday, December 6 REDWOOD CITY, Calif., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of


Stock Market & Investing Books

Enter a stock symbol to view the stock details.